Reimbursement Request Information
Visit us at ASCRS in San Diego

Join us at ASCRS in San Diego on May 6-8, 2023

Join us at ASCRS in San Diego on May 6-8, 2023

Booth #1124
San Diego Convention Center
Booth #1124
San Diego Convention Center
IN-BOOTH SPEAKER FORUM
Join us at ASCRS, booth 1124, to participate in peer-to-peer educational discussions with twelve glaucoma experts about the benefits of performing implant-free and minimally invasive procedures with the OMNI Surgical System. An excellent opportunity to ask questions and learn best practices.
Saturday, May 6
10:00 AM
Nine Reasons Why We Perform MIGS with OMNI
Neda Shamie, MD
Philip Ngai, MD
Noureen Khan, MD
Saturday, May 6
1:30 PM
Standalone MIGS: What Are You Waiting For?
Jai Parekh MD, MBA
Christine Funke, MD
Douglas McGraw, MD
Sunday, May 7
11:30 AM
MIGS Beyond Cataract Surgery: An Interventional Mindset
Ike Ahmed, MD
Felise May Barte, MD
Lawrence Woodard, MD
Sunday, May 7
1:00 PM
OMNI Surgical System: What the Data Says
Sameh Mosaed, MD
Shamik Bafna, MD
Syril Dorairaj, MD
Booth events are not part of the official ASCRS program.
The twelve presenters are paid consultants of Sight Sciences.
Advancement has never
felt so good
Watch Video
KEY FEATURES OF THE ERGO SERIES
New Cannula Tip Design
The cannula tip has a new profile that enables gentle and precise access to Schlemm’s canal while continuing to enable full 360-degree catheterization associated with the OMNI procedure.
Improved Handle Ergonomics
New enhancements enable surgeons to more easily rotate and position the cannula tip within Schlemm’s canal with precise finger rotations versus wrist adjustments
Simplified Viscoelastic Preparation
The handle’s viscoelastic luer connector is now removable and detaches when the viscoelastic cartridge is removed, resulting in more clearance with the surgical microscope
OMNI ON THE PODIUM
OMNI will be featured in the following oral presentations, which are part of the official ASCRS program.
Canaloplasty and Trabeculotomy with Cataract Surgery in Eyes with Primary Open-Angle Glaucoma (POAG): Two Year Outcomes from the ROMEO Study
Oral presentation by Blake Williamson, MD
Saturday, May 6, 2023
1:50-1:55pm
SDCC Upper Level, Rm 5B
Visit ASCRS website
Canaloplasty and Trabeculotomy in POAG Refractory to Medication and Prior Trabecular Microbypass Stenting
Oral presentation by Daniel Terveen, MD
Sunday, May 7, 2023
2:50-2:55pm
SDCC, Upper Level, Rm 1B
Visit ASCRS website
Glaucoma Medication Use in Patients with a Mild Glaucoma Severity After Receiving MIGS: An Academy IRIS® Registry Analysis
Oral presentation by Michael Mbagwu, MD
Sunday, May 7, 2023
2:05-2:10pm
SDCC, Upper Level, Rm 1B
Visit ASCRS website
WHAT THE EXPERTS SAY
GET TO KNOW OMNI TODAY

    State

    Important Product Information

    OMNI® Surgical System IMPORTANT PRODUCT INFORMATION
    Indications for Use

    The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma.

    Contraindications

    Do not use the OMNI® in any situations where the iridocorneal angle is compromised or has been damaged (e.g., from trauma or surgery), since it may not be possible to visualize the angle or to properly pass the microcatheter.

    Do not use the OMNI® in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris.

    Do not use the OMNI® Surgical System in quadrants with previous MIGS implants.

    Please refer to the full Instructions for Use, available HERE, for warnings, precautions, and adverse event information.

    Warnings

    1. Do not use in cases where there is insufficient visibility to properly see the iridocorneal angle. The following conditions may prohibit sufficient visualization required for safe and successful cannula and microcatheter placement: corneal edema, corneal haze, corneal opacity, or any other conditions that may inhibit gonioscopic view of the iridocorneal angle and intended cannula entry location.

    2. Perform gonioscopy prior to taking a patient to surgery to exclude congenital anomalies of the iridocorneal angle, anterior segment dysgeneses, peripheral anterior synechiae (PAS), rubeosis, and any other angle abnormalities that could lead to improper placement of the cannula and microcatheter and pose a hazard.

    3. Maintain direct microscopic or gonioscopic visualization of the cannula tip and microcatheter tip at all times during the procedure to facilitate advancement and to avoid inadvertently damaging intraocular structures, kinking the microcatheter or unintended tearing of trabecular meshwork.

    4. The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure. If intraocular pressure is not adequately maintained after surgery, the surgeon should initiate appropriate management of intraocular pressure.

    Potential adverse events

    Adverse events that may be reasonably associated with the use of the OMNI® System in the eye include, but are not limited to, the following: anterior chamber shallowing, severe, prolonged, or persistent intraocular inflammation, endophthalmitis or other ocular infection, aqueous misdirection, Descemet’s membrane tear or detachment, intracorneal hematoma, choroidal effusion, suprachoroidal hemorrhage, corneal decompensation, corneal injury, corneal edema or opacification, unintended trabeculotomy, cyclodialysis cleft, hyphema, hypopyon, hypotony, hypotony maculopathy, IOL dislocation, cataract formation, iris injury, tear, or iridodialysis, loss of vitreous, perforation of sclera, posterior capsular bag rupture, proliferative vitreoretinopathy, pupillary block, pupillary membrane formation, retinal detachment, retinal dialysis, retinal flap tears, secondary surgical intervention, including, but not limited to, glaucoma surgery, and vitreous hemorrhage. Federal (USA) law restricts this device to sale, distribution, or use by or on the order of a physician.

    Thank you for message

    We appreciate your interest in the OMNI Surgical System. A member of our team will review your inquiry and get back to you as soon as possible during business hours.

    Thank you for your interest in the OMNI® Surgical System.
    A member of our team will follow up with you shortly.